Conversely, the apoE4 isoform is the strongest genetic risk factor identified to date for developing late-onset AD, and it is associated with an increased accumulation of Aβ in the brain as well as tau-associated neurodegeneration [55,56]. This evidence concerns the gene MAPT and Alzheimer disease.